Founders
Dr. med Johannes Reinmüller, Chairman: Surgeon and medical researcher with over 30 years’ experience.
Owner and managing director of the Klinik am Sonnenberg, Wiesbaden, Germany.
Dr. Viktoria Reinmüller, CSO: Cancer researcher with over 10 years’ experience.
Trained at Johannes Gutenberg University Mainz, Germany (Dipl. Chem.), Roche Basel, and EPFL Lausanne,
Switzerland (Ph.D. in cancer drug discovery).
Dr. Roman Marty, COO: Chemistry researcher with over 10 years’ experience.
Trained at ETH Zürich (MSc Chemistry), Roche Basel, and EPFL Lausanne, Switzerland (Ph.D. in biomimetic materials).
Scientific
Heidi Lane, Ph.D.: Advisor for science and R&D strategy.
Cancer drug development and translational science expert with over 20 years’ experience in Big Pharma (Novartis)
and Biopharma (Basilea Pharmaceutica Ltd). Current position: Consultant Cancer Drug Development.
Pavel Pisa, M.D. Ph.D.: Advisor for oncology and translational medicine.
Medical expert in all stages of drug development in oncology with over 30 years’ experience in academia (Karolinska)
and big pharma (Roche). Current position: Founder and CEO of piMed Consulting.
Advisors
Prof. Tariq Mughal, M.D. Ph.D.: Advisor for preclinical and clinical development.
Clinical oncologist with over 30 years’ experience.
Current positions: Professor of Medicine at the Tufts University School of Medicine in Boston, Massachusetts,
and scholar in precision oncology at City of Hope in Duarte, California.
Business/
Finance
Urmi Prasad Richardson: Advisor for business strategy pharma.
Global biopharma executive with over 25 years’ experience (Pfizer, Novartis, Foundation Medicine).
Current position: President EMEA Thermo Fisher Scientific.
Thomas Stapp: Advisor for finance. Global business and management consultant with over 15 years’ experience.
Former CFO at Constellation Acquisition. Current position: Investor and entrepreneur, Bain external advisor.
